New drug outperforms standard diabetic vision loss treatments

Stephen FellerBETHESDA, Md., Feb. 29 (UPI) -- In a trial, Eylea outperformed Avastin at returning vision for some diabetic macular edema patients, and about as well as other drugs for most patients.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news